Compared with normal colon cancer cells, ropivacaine could up-regulate the expression of Bax, caspase-3, a-caspase-3, caspase-9, a-caspase-9, and down-regulate the expression of bcl-2. Here, BCL2 is linked to malignant colon neoplasm.